MYGN Stock Ownership Activity

MYRIAD GENETICS INC 13F holders

No value investing guru has made any change to the MYRIAD GENETICS INC (MYGN) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying MYGN now?

According to the latest SEC filing(s) MYRIAD GENETICS INC (MYGN) has not been purchased by any super investor.

To see more about who is investing in MYRIAD GENETICS INC (MYGN), please go to the MYGN ownership page.

2014 Q2 (3 results)
Ole Andreas Halvorsen
buy
+1,330,294
+0.23%
0.00%
Fred Martin
-3.02%
-26,180
-0.03%
0.85%
Chase Coleman III
-19.01%
-445,921
-0.24%
1.04%
Current price: $4.40 88.69% AVG reported price*: $38.92
2014 Q1 (3 results)
Chase Coleman III
+95.15%
+1,143,821
+0.53%
1.09%
Fred Martin
+4.65%
+38,475
+0.03%
0.75%
Marty Whitman
-100.00%
-328,314
-0.13%
0.00%
Current price: $4.40 87.13% AVG reported price*: $34.19
2013 Q4 (4 results)
Marty Whitman
buy
+328,314
+0.12%
0.00%
Chase Coleman III
buy
+1,202,100
+0.32%
0.32%
Fred Martin
+4.17%
+33,157
+0.02%
0.45%
Ronald Muhlenkamp
-100.00%
-484,765
-2.02%
0.00%
Current price: $4.40 79.03% AVG reported price*: $20.98
2013 Q3 (2 results)
Fred Martin
+2.63%
+20,360
+0.01%
0.54%
Ronald Muhlenkamp
+0.59%
+2,865
+0.01%
0.00%
Current price: $4.40 81.28% AVG reported price*: $23.50
2013 Q2 (2 results)
Ronald Muhlenkamp
buy
+481,900
+2.73%
2.73%
Fred Martin
buy
+774,520
+0.67%
0.67%
Current price: $4.40 83.62% AVG reported price*: $26.87
14 of 62

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.